Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01512992
Other study ID # RH_pilotCAT
Secondary ID EC Grant Agreeme
Status Active, not recruiting
Phase N/A
First received January 16, 2012
Last updated September 4, 2013
Start date April 2012
Est. completion date December 2013

Study information

Verified date September 2013
Source Catalan Agency for Health Information, Assessment and Quality
Contact n/a
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the effects of a complex telemedicine intervention as a part of an integrated care program for patients with chronic obstructive pulmonary disease (COPD) discharged from the hospital after disease exacerbation. Will be evaluated whether the intervention produces benefits in terms of mortality, reduction in hospital readmissions and health-related quality of life. In addition, the trial evaluates the economical and organizational impact of the new service and examines its acceptability by patients and health professionals.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 380
Est. completion date December 2013
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender Both
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Exacerbation of COPD

- Age > 40 years

- Capability to use the devices provided

- Willing to participate

Exclusion Criteria:

• Participation in a previous COPD home telehealth study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Procedure:
Home telehealth
Patients receive tailored intervention according to their clinical complexity. All patients in the intervention group receive: Personalised care plan Education on self-management Access to a personalized online health folder Access to Call center Access to primary care and hospital specialists; follow-up visits for evaluation of clinical recovery and care plan adjustments (if needed). Patients with LOW complexity additionally receive: Daily videoconferences for the 1st week after discharge Remote monitoring for respiratory parameters. Sensors are selected on an individual basis by the medical specialists. Patients with HIGH complexity additionally receive: Videoconferences for at least 1 month after discharge, scheduled on an individual basis. Remote monitoring for respiratory parameters. One monthly phone call from the call centre to promote and assess patient self-management.

Locations

Country Name City State
Spain Hospital Germans Trias i Pujol Badalona Catalonia
Spain Capio Hospital Universitari Sagrat Cor Barcelona Catalonia
Spain Hospital Clinic de Barcelona Barcelona Catalonia
Spain Hospital del Mar Barcelona Catalonia
Spain Hospital Plató Barcelona Catalonia
Spain Hospital de Mataró Mataró Catalonia
Spain Hospital Parc Taulí Sabadell Catalonia
Spain Consorci Sanitari de Terrassa Terrassa Catalonia

Sponsors (4)

Lead Sponsor Collaborator
Catalan Agency for Health Information, Assessment and Quality Fundació TicSalut, Hospital Clinic of Barcelona, Hospital de Mataró

Country where clinical trial is conducted

Spain, 

References & Publications (3)

Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernández C, Alonso A, del Pozo F, de Toledo P, Antó JM, Rodríguez-Roisín R, Decramer M; members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006 Jul;28(1):123-30. Epub 2006 Apr 12. — View Citation

Finkelstein SM, Speedie SM, Potthoff S. Home telehealth improves clinical outcomes at lower cost for home healthcare. Telemed J E Health. 2006 Apr;12(2):128-36. — View Citation

Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Scott RE. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare. 2010;16(3):120-7. doi: 10.1258/jtt.2009.090812. Epub 2010 Mar 2. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of hospital readmissions 3 months period No
Secondary Health related quality of life of the patients as measured by the SF-36 v2 questionnaire 3 months - at baseline and study end No
Secondary Hospital anxiety and depression scale HADS 3 months - at baseline and study end No
Secondary Lung condition as measured by FEV1 3 months - at baseline and study end No
Secondary Condition-related health status measured by COPD Assessment Test (CAT) 3 months - at baseline and study end No
Secondary Mortality 3 months period No
Secondary Patients' Acceptance-Satisfaction measured by the WSD Questionnaire at the 3rd month of the telehealth intervention No
Secondary Time in days to first readmission 3 months period No
Secondary Length of stay in days for each readmission 3 months period No
Secondary Number of emergency room visits at the 3rd month (end of trial) No
See also
  Status Clinical Trial Phase
Completed NCT05043428 - The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD N/A
Completed NCT00528996 - An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. Phase 2
Completed NCT03740373 - A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate Phase 1
Completed NCT05393245 - Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
Completed NCT05402020 - Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
Completed NCT04011735 - Re-usable Respimat® Soft MistTM Inhaler Study
Enrolling by invitation NCT03075709 - The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
Completed NCT03764163 - Image and Model Based Analysis of Lung Disease Early Phase 1
Completed NCT00515268 - Endotoxin Challenge Study For Healthy Men and Women Phase 1
Completed NCT04085302 - TARA Working Prototype Engagement Evaluation: Feasibility Study N/A
Completed NCT03691324 - Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study N/A
Completed NCT02236611 - A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT00153075 - Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT01017952 - A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01009463 - A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT04882124 - Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD Phase 2
Completed NCT02853123 - Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients Phase 4
Completed NCT02619357 - Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma Phase 1
Recruiting NCT05858463 - High Intensity Interval Training and Muscle Adaptations During PR N/A
Not yet recruiting NCT05032898 - Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II